Fluzone® (IM)

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Stanford University

Conditions

Influenza

Phase 2

Immunogenicity and Safety of Different Doses of Fluzone® Influenza

CompletedNCT00253734

National Institute of Allergy and Infectious Diseases (NIAID)Influenza

Start: 2005-11-30End: 2006-11-30Updated: 2013-06-03

Phase 4

Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014)

CompletedNCT02141581

Stanford UniversityInfluenza

Start: 2011-08-31End: 2014-12-31Updated: 2018-05-07